PDS Biotechnology Corp (PDSB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

25B VREELAND ROAD FLORHAM PARK, NJ 07932

PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.

Data as of 2021-08-02 08:46:58 -0400
Market Cap302.671 Million Shares Outstanding28.366 Million Avg 30-day Volume563.967 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.93 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.70817 52-week High/Low13.48 / 1.84 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PDSB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 32 30 6.67% 9 (0.53%) 9 (0.52%) 0.0%
13F shares: 3.141 Million 3.145 Million -0.13% 1.697 Million 1.361 Million 24.73%
% Ownership 14.1103 14.1289 -0.13% 7.6234 6.112 24.73%
New Positions: 11 7 57.14% 3 2 50.0%
Increased Positions 8 8 0.0% 2 2 0.0%
Closed Positions 9 7 28.57% 3 1 200.0%
Reduced Positions 7 2 250.0% 1 1 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PDSB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PDSB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

51.2 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

56.1 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SYKES RICHARD

9,000 2021-06-17 1

ILIEV ILIAN

9,000 2021-06-17 1

BRAWLEY OTIS W

9,000 2021-06-17 3

BLOOMQUIST DELYLE W

  • SEE REMARKS
804,941 2021-06-16 1

FREITAG GREGORY GENE

55,153 2021-06-15 1

BEDU-ADDO FRANK PRESIDENT/CEO

646,515 2021-06-15 2

GLOVER STEVE C

72,790 2021-06-15 1

ALI-JACKSON KAMIL

20,764 2021-06-15 1

VAN VOORHEES SETH CHIEF FINANCIAL OFFICER

17,647 2021-06-15 3

WOOD LAUREN CHIEF MEDICAL OFFICER

0 2020-12-08 1

CONN GREGORY CHIEF SCIENTIFIC OFFICER

0 2020-12-08 1

KING MICHAEL N. INTERIM CFO

0 2020-12-08 1

TROCHIMIUK JANETTA PRINCIPAL ACCOUNTING OFFICER

0 2020-03-23 0

SAIK ANDREW CHIEF FINANCIAL OFFICER

42,549 2020-02-14 0

LOUGHLIN JAMES J

  • Director
0 2019-06-28 0

MIDDLEKAUFF W BRADFORD SENIOR VP, GC AND SECRETARY

  • Officer
73,770 2019-03-18 0

LEUTHNER BRIAN A PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2019-03-15 0

BLECH ISAAC

  • Director
No longer subject to file 2019-03-15 0

BARER SOL J

  • Director
678,075 2019-03-15 0

MACDONALD R. LOCH

  • Director
No longer subject to file 2019-03-15 0

SPIEGEL ROBERT J.

  • Director
48,661 2019-03-15 0

RATCLIFFE LIAM

  • Director
No longer subject to file 2019-03-15 0

CRANE ROSEMARY A

  • Director
No longer subject to file 2019-03-15 0

WYANT ALYSSA SVP REGULATORY AFFAIRS

  • Officer
No longer subject to file 2018-08-15 0

MARCHIO ALBERT N II CHIEF ACCOUNTING & ADM OFFICER

  • Officer
0 2018-08-14 0

FALECK HERBERT J CHIEF MEDICAL OFFICER

  • Officer
0 2018-08-14 0

CONTI KURT G

  • Director
1,113,961 2018-03-23 0

BRENNAN DANIEL CHIEF OPERATING OFFICER

  • Officer
0 2018-03-01 0

HEALY JAMES

  • Director
0 2017-06-20 0

YAMAN ALPASLAN V.P., TECHNICAL OPS. & MFG.

  • Officer
0 2017-03-13 0

EINHORN ANDREW J. CHIEF FINANCIAL OFFICER

  • Officer
126,815 2017-03-01 0

RATCLIFFE LIAM

NEW LEAF VENTURE PARTNERS, L.L.C.

  • Director
0 2016-06-21 0

RATCLIFFE LIAM

NEW LEAF VENTURES III, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURE PARTNERS, L.L.C.

  • Director
1,172,434 2016-06-21 0

VAISH RENU V.P., GLOBAL REG. AFFAIRS

  • Officer
5,350 2016-06-16 0

HOVE ANDERS D

  • Director
2,068,582 2015-10-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GLOVER STEVE C

2021-06-17 19:15:26 -0400 2021-06-17 A 9,000 a 9,000 direct

SYKES RICHARD

2021-06-17 19:03:49 -0400 2021-06-17 A 9,000 a 9,000 direct

FREITAG GREGORY GENE

2021-06-17 18:45:33 -0400 2021-06-17 A 9,000 a 9,000 direct

BRAWLEY OTIS W

2021-06-17 19:20:51 -0400 2021-06-17 A 9,000 a 9,000 direct

ALI-JACKSON KAMIL

2021-06-17 19:09:59 -0400 2021-06-17 A 9,000 a 9,000 direct

ILIEV ILIAN

2021-06-17 18:58:23 -0400 2021-06-17 A 9,000 a 9,000 direct

BLOOMQUIST DELYLE W SEE REMARKS

2021-06-21 16:30:48 -0400 2021-06-16 P 10,000 $9.88 a 193,888 direct 2.7128 9.5416 9.5416 5 0.0 1

BLOOMQUIST DELYLE W SEE REMARKS

2021-06-21 16:30:48 -0400 2021-06-16 M 2,970 $5.99 a 183,888 direct 2.7128 9.5416 9.5416 5 0.0 1

BLOOMQUIST DELYLE W SEE REMARKS

2021-06-21 16:30:48 -0400 2021-06-16 M 2,970 d 6,030 direct

FREITAG GREGORY GENE

2021-06-17 18:45:33 -0400 2021-06-15 P 5,882 $8.50 a 46,153 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

BEDU-ADDO FRANK PRESIDENT/CEO

2021-06-17 19:26:07 -0400 2021-06-15 F 27,166 $12.86 d 646,515 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

ALI-JACKSON KAMIL

2021-06-17 19:09:59 -0400 2021-06-15 P 11,764 $8.50 a 11,764 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

VAN VOORHEES SETH CHIEF FINANCIAL OFFICER

2021-06-17 18:52:14 -0400 2021-06-15 P 17,647 $8.50 a 17,647 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

BEDU-ADDO FRANK PRESIDENT/CEO

2021-06-17 19:26:07 -0400 2021-06-15 M 53,174 $6.57 a 673,681 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

GLOVER STEVE C

2021-06-17 19:15:26 -0400 2021-06-15 P 5,882 $8.50 a 63,790 direct -2.4306 -4.5139 -4.6875 8.941 9 -19.0104 27

BEDU-ADDO FRANK PRESIDENT/CEO

2021-06-17 19:26:07 -0400 2021-06-15 M 53,174 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 15:45:03 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 15:15:03 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 14:45:04 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 14:15:03 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 13:45:03 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 13:15:03 UTC -7.5848 7.6448 1400000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-03 12:45:03 UTC -7.5848 7.6448 1300000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 22:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 21:45:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 21:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 20:45:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 20:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 19:45:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 19:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 18:45:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 18:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 17:45:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 17:15:03 UTC -7.5848 7.6448 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 16:45:03 UTC -7.5865 7.6665 1500000
PDS BIOTECHNOLOGY CORP PDSB 2021-08-02 16:15:03 UTC -7.5865 7.6665 1500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments